Marilyn Leitch

5.3k total citations · 1 hit paper
18 papers, 1.5k citations indexed

About

Marilyn Leitch is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Marilyn Leitch has authored 18 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 8 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Marilyn Leitch's work include Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (5 papers) and Global Cancer Incidence and Screening (2 papers). Marilyn Leitch is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (5 papers) and Global Cancer Incidence and Screening (2 papers). Marilyn Leitch collaborates with scholars based in United States, South Korea and Peru. Marilyn Leitch's co-authors include David Euhus, Peter D. Beitsch, Barbara Haley, Nancy Lane, Larry E. Morrison, Jianqiang Wang, Dorothee Herlyn, Jonathan W. Uhr, Eugene P. Frenkel and Sanjay Shete and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer.

In The Last Decade

Marilyn Leitch

16 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circulating Tumor Cells in Patients with Breast Cancer Dormancy

2004 778 citations Songdong Meng, Debasish Tripathy et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Marilyn Leitch

Since Specialization

Citations

This map shows the geographic impact of Marilyn Leitch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilyn Leitch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilyn Leitch more than expected).

Fields of papers citing papers by Marilyn Leitch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marilyn Leitch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilyn Leitch. The network helps show where Marilyn Leitch may publish in the future.

Co-authorship network of co-authors of Marilyn Leitch

This figure shows the co-authorship network connecting the top 25 collaborators of Marilyn Leitch. A scholar is included among the top collaborators of Marilyn Leitch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilyn Leitch. Marilyn Leitch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Factors Associated with Nodal Positivity Following Neoadjuvant Systemic Therapy in Breast Cancer Patients Who are Initially Node-Negative on MRI 2025 ·Annals of Surgical Oncology ·(unknown), (unknown), (unknown), Yin Xi, Sunati Sahoo, Marilyn Leitch, Heather L. McArthur, Başak E. Doğan	0
2	Intraoperative evaluation of sentinel lymph nodes in patients with breast cancer treated with systemic neoadjuvant therapy 2023 ·Journal of Clinical Pathology ·(unknown), Mariam Mir, (unknown), Helena Hwang, Venetia Sarode, Yan Peng, Yisheng Fang, Marilyn Leitch, Sunati Sahoo	0
3	Novel hyaluronan formulation for preventing acute skin reactions in breast during radiotherapy: a randomized clinical trial 2019 ·Supportive Care in Cancer ·Asal Rahimi, Osama Mohamad, Kevin Albuquerque, (unknown), Diana Chen, K. Thomas, (unknown), Aeisha Rivers, Marilyn Leitch, Roshni Rao, Barbara Haley, Chul Ahn, Dan Garwood, Ann Spangler	9
4	Constructing a Clinicopathologic Prognostic Model for Triple-Negative Breast Cancer 2017 ·K. Thomas, (unknown), Roshni Rao, Abu Minhajuddin, Ann Spangler, Marilyn Leitch, (unknown), Aeisha Rivers, Barbara Haley, Nathan Kim, (unknown)	3
5	Preliminary Results of a Phase 1 Dose-Escalation Trial for Early-Stage Breast Cancer Using 5-Fraction Stereotactic Body Radiation Therapy for Partial-Breast Irradiation 2017 ·International Journal of Radiation OncologyBiologyPhysics ·Asal Rahimi, K. Thomas, Ann Spangler, Roshni Rao, Marilyn Leitch, (unknown), Aeisha Rivers, Stephen Seiler, Kevin Albuquerque, (unknown), Sally Goudreau, Dan Garwood, Barbara Haley, David Euhus, J.H. Heinzerling, Chuxiong Ding, Ang Gao, Chul Ahn, Robert Timmerman	49
6	Bracketed radioactive seed localization vs bracketed wire-localization in breast surgery 2017 ·The Breast Journal ·(unknown), (unknown), Ali A. Mokdad, Stephen Seiler, (unknown), Aeisha Rivers, (unknown), (unknown), E. Sherwood Brown, (unknown), Deborah Farr, (unknown), (unknown), Marilyn Leitch, Roshni Rao	9
7	Genetic Ancestry using Mitochondrial DNA in patients with Triple‐negative breast cancer (GAMiT study) 2016 ·Cancer ·Roshni Rao, Aeisha Rivers, Asal Rahimi, (unknown), (unknown), Marilyn Leitch, David Euhus, Barbara Haley	6
8	DEVELOPMENT AND INITIATION OF A CLINICAL PROTOCOL FOR THE TREATMENT OF IDIOPATHIC GRANULOMATOUS MASTITIS 2014 ·(unknown), (unknown), Marilyn Leitch, David Euhus, James F. Huth, Roshni Rao	5
9	Identification of Breast Cancer DNA Methylation Markers Optimized for Fine-Needle Aspiration Samples 2013 ·Cancer Epidemiology Biomarkers & Prevention ·Dawei Bu, Cheryl Lewis, Venetia Sarode, Min Chen, Xiaotu Ma, (unknown), Roshni Rao, Marilyn Leitch, Amy Moldrem, Valerie Andrews, Adi F. Gazdar, David Euhus	11
10	Outcomes of Delays in Time to Treatment in Triple Negative Breast Cancer 2013 ·Annals of Surgical Oncology ·(unknown), (unknown), Amy Moldrem, Valerie Andrews, James F. Huth, David Euhus, Marilyn Leitch, Roshni Rao	29
11	A randomised trial of nursing interventions supporting recovery of the postmastectomy patient 2012 ·Journal of Clinical Nursing ·(unknown), Gail C. Davis, (unknown), Roshni Rao, Shihua Zhao, Xian‐Jin Xie, (unknown), (unknown), (unknown), Marilyn Leitch	13
12	Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031 2011 ·Journal of Clinical Oncology ·Matthew J. Ellis, Vera J. Suman, Jeremy Hoog, Lin Li, Jacqueline Snider, Aleix Prat, Joel S. Parker, Jingqin Luo, Katherine DeSchryver, D. Craig Allred, Laura J. Esserman, Gary Unzeitig, Julie Margenthaler, Gildy V. Babiera, P. Kelly Marcom, Joseph M. Guenther, Mark A. Watson, Marilyn Leitch, Kelly K. Hunt, John A. Olson	365
13	Primary breast tumor characteristics predicting aggressive nodal involvement 2007 ·The American Journal of Surgery ·Aye Moe Thu, Monet W. Bowling, Marilyn Leitch, Roshni Rao, David Euhus	2
14	uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues 2006 ·Proceedings of the National Academy of Sciences ·Songdong Meng, Debu Tripathy, Sanjay Shete, Raheela Ashfaq, Hossein Saboorian, Barbara Haley, Eugene P. Frenkel, David Euhus, Marilyn Leitch, Cynthia R. Osborne, Edward Clifford, Steve Perkins, Peter D. Beitsch, Amanullah Khan, Larry E. Morrison, Dorothee Herlyn, Leon W.M.M. Terstappen, Nancy Lane, Jianqiang Wang, Jonathan W. Uhr	127
15	A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the american college of surgeons oncology group 2004 ·Journal of the American College of Surgeons ·Lisa A. Newman, Thelma C. Hurd, Marilyn Leitch, Henry M. Kuerer, Kathleen M. Diehl, Anthony Lucci, Armando E. Giuliano, Kelly K. Hunt, (unknown), Samuel A. Wells	32
16	Circulating Tumor Cells in Patients with Breast Cancer Dormancy breakdown → 2004 ·Clinical Cancer Research ·Songdong Meng, Debasish Tripathy, Eugene P. Frenkel, Sanjay Shete, Elizabeth Z. Naftalis, James F. Huth, Peter D. Beitsch, Marilyn Leitch, Susan Hoover, David Euhus, Barbara Haley, Larry E. Morrison, Timothy P. Fleming, Dorothee Herlyn, Leon W.M.M. Terstappen, Tanja Fehm, Thomas F. Tucker, Nancy Lane, Jianqiang Wang, Jonathan W. Uhr	778
17	What's New in Surgical Oncology 2001 ·Journal of the American College of Surgeons ·Marilyn Leitch	1
18	Sentinel lymph node biopsy, an alternative to elective axillary dissection for breast cancer 1998 ·The American Journal of Surgery ·Fiemu E. Nwariaku, David Euhus, Peter D. Beitsch, Edward Clifford, William Erdman, Dana Mathews, Jorge Albores‐Saavedra, Marilyn Leitch, George N. Peters	70

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact